Diabetes
55:1066-1073,
2006
DOI: 10.2337/diabetes.55.04.06.db05-1266
© 2006 by the American Diabetes Association
Inhibition of Glucose-Stimulated Activation of Extracellular Signal–Regulated Protein Kinases 1 and 2 by Epinephrine in Pancreatic ß-Cells
Tara Beers Gibson1,
Michael C. Lawrence1,
Craig J. Gibson2,
Colleen A. Vanderbilt1,
Kathleen McGlynn1,
Don Arnette1,
Wei Chen1,
Julie Collins1,
Bashoo Naziruddin3,
Marlon F. Levy3,
Barbara E. Ehrlich2, and
Melanie H. Cobb1
1 Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
2 Departments of Pharmacology and Cellular and Molecular Physiology, Yale University, New Haven, Connecticut
3 cGMP Islet Cell Processing Laboratory, Islet Cell Transplant Program, Baylor University Medical Center, Dallas, Texas
Address correspondence and reprint requests to Melanie H. Cobb, Department of Pharmacology, UT Southwestern Medical Center, 6001 Forest Park Rd., Dallas, TX 75390-9041. E-mail: melanie.cobb{at}utsouthwestern.edu
Abbreviations:
ER, endoplasmic reticulum; ERK1/2, extracellular signal–regulated kinases 1 and 2; GLP, glucagon-like peptide; KRBH, Krebs-Ringer bicarbonate HEPES; MAP, mitogen-activated protein; PKA, protein kinase A; SERCA, sarcoplasmic reticulum/endoplasmic reticulum ATPase
Glucose sensing is essential for the ability of pancreatic ß-cells to produce insulin in sufficient quantities to maintain blood glucose within the normal range. Stress causes the release of adrenergic hormones that increase circulating glucose by promoting glucose production and inhibiting insulin release. We have shown that extracellular signal–regulated kinases 1 and 2 (ERK1/2) are responsive to glucose in pancreatic ß-cells and that glucose activates ERK1/2 by mechanisms independent of insulin. Here we show that glucose-induced activation of ERK1/2 is inhibited by epinephrine through the 2-adrenergic receptor. Epinephrine and the selective 2-adrenergic agonist UK14304 reduced insulin secretion and glucose-stimulated ERK1/2 activation in a pertussis toxin–sensitive manner, implicating the subunit of a Gi family member. 2-adrenergic agonists also reduced stimulation of ERK1/2 by glucagon-like peptide 1 and KCl, but not by phorbol ester or nerve growth factor. Our findings suggest that 2-adrenergic agonists act via a Gi family member on early steps in ERK1/2 activation, supporting the idea that ERK1/2 are regulated in a manner that reflects insulin demand.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Lawrence, K. McGlynn, B. Naziruddin, M. F. Levy, and M. H. Cobb
Inaugural Article: Differential regulation of CHOP-10/GADD153 gene expression by MAPK signaling in pancreatic beta-cells
PNAS,
July 10, 2007;
104(28):
11518 - 11525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cheng, S. G. Straub, and G. W. G. Sharp
Inhibitory role of Src family tyrosine kinases on Ca2+-dependent insulin release
Am J Physiol Endocrinol Metab,
March 1, 2007;
292(3):
E845 - E852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-u. Choe and B. E. Ehrlich
The Inositol 1,4,5-Trisphosphate Receptor (IP3R) and Its Regulators: Sometimes Good and Sometimes Bad Teamwork
Sci. Signal.,
November 28, 2006;
2006(363):
re15 - re15.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|